Antibiotics as Major Disruptors of Gut Microbiota
- PMID: 33330122
- PMCID: PMC7732679
- DOI: 10.3389/fcimb.2020.572912
Antibiotics as Major Disruptors of Gut Microbiota
Abstract
Advances in culture-independent research techniques have led to an increased understanding of the gut microbiota and the role it plays in health and disease. The intestine is populated by a complex microbial community that is organized around a network of metabolic interdependencies. It is now understood that the gut microbiota is vital for normal development and functioning of the human body, especially for the priming and maturation of the adaptive immune system. Antibiotic use can have several negative effects on the gut microbiota, including reduced species diversity, altered metabolic activity, and the selection of antibiotic-resistant organisms, which in turn can lead to antibiotic-associated diarrhea and recurrent Clostridioides difficile infections. There is also evidence that early childhood exposure to antibiotics can lead to several gastrointestinal, immunologic, and neurocognitive conditions. The increase in the use of antibiotics in recent years suggests that these problems are likely to become more acute or more prevalent in the future. Continued research into the structure and function of the gut microbiota is required to address this challenge.
Keywords: antibiotic overuse; antibiotic resistance; antibiotic-associated diarrhea (AAD); enterotypes; gut microbiota; microbial diversity.
Copyright © 2020 Ramirez, Guarner, Bustos Fernandez, Maruy, Sdepanian and Cohen.
Conflict of interest statement
FG is a member of the advisory boards at Biocodex and Instituto Danone; and has received research grants from AB Biotics, Takeda and Abbvie. AM is a speaker and member of the advisory board at Biocodex France. HC is an advisor for Biocodex and Megapharma. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Response of the gut microbiota during the Clostridioides difficile infection in tree shrews mimics those in humans.BMC Microbiol. 2020 Aug 20;20(1):260. doi: 10.1186/s12866-020-01943-z. BMC Microbiol. 2020. PMID: 32819295 Free PMC article.
-
[Side effects of antibiotic: diarrhea and Clostridium difficile infection.].Recenti Prog Med. 2021 Jan;112(1):4-26. doi: 10.1701/3551.35254. Recenti Prog Med. 2021. PMID: 33576348 Italian.
-
The microbial diversity following antibiotic treatment of Clostridioides difficile infection.BMC Gastroenterol. 2021 Apr 13;21(1):166. doi: 10.1186/s12876-021-01754-0. BMC Gastroenterol. 2021. PMID: 33849457 Free PMC article.
-
The role of gut microbiota in Clostridium difficile infection.Eur J Intern Med. 2018 Apr;50:28-32. doi: 10.1016/j.ejim.2018.02.006. Epub 2018 Feb 7. Eur J Intern Med. 2018. PMID: 29428498 Review.
-
Clostridium difficile Infection: A Model for Disruption of the Gut Microbiota Equilibrium.Dig Dis. 2016;34(3):217-20. doi: 10.1159/000443355. Epub 2016 Mar 30. Dig Dis. 2016. PMID: 27028327 Review.
Cited by
-
Fecal microbiota transplantation accelerates restoration of florfenicol-disturbed intestinal microbiota in a fish model.Commun Biol. 2024 Aug 17;7(1):1006. doi: 10.1038/s42003-024-06727-z. Commun Biol. 2024. PMID: 39152200 Free PMC article.
-
Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments.Curr Gastroenterol Rep. 2024 Aug 15. doi: 10.1007/s11894-024-00939-3. Online ahead of print. Curr Gastroenterol Rep. 2024. PMID: 39145848 Review.
-
Evaluating the pharmacological activities of Aloe perryi-Silver nanoparticles induced apoptosis against colon cancer cells (HCT-116).Food Sci Nutr. 2024 May 27;12(8):5890-5906. doi: 10.1002/fsn3.4246. eCollection 2024 Aug. Food Sci Nutr. 2024. PMID: 39139937 Free PMC article.
-
Probiotic Functions in Fermented Foods: Anti-Viral, Immunomodulatory, and Anti-Cancer Benefits.Foods. 2024 Jul 28;13(15):2386. doi: 10.3390/foods13152386. Foods. 2024. PMID: 39123577 Free PMC article. Review.
-
Antibiotic Management for Early-Onset Sepsis in Neonates With Gestational Ages of ≥ 34 Weeks: The Kaiser Sepsis Calculator Versus the 2010 CDC Guidelines.Cureus. 2024 Jul 2;16(7):e63704. doi: 10.7759/cureus.63704. eCollection 2024 Jul. Cureus. 2024. PMID: 39092365 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources